Login / Signup

Content validation of the SF-36v2® Health Survey Acute for use in hypoparathyroidism.

Meryl BrodLaura Tesler WaldmanAimee D ShuAlden Smith
Published in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2023)
The study findings show that the items in the SF-36v2® are applicable to adults with HP. The overall high levels of endorsement of items provide strong evidence of the measure's content validity for this population. The SF-36v2 is therefore recommended for usage in clinical trials examining adults with HP, although it is recommended that this generic measure be supplemented with disease-specific instruments such as the recently developed Hypoparathyroidism Patient Experience Scale-Symptom (HPES-Symptom) and Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact) measures.
Keyphrases
  • clinical trial
  • liver failure
  • respiratory failure
  • patient reported
  • randomized controlled trial
  • intensive care unit
  • acute respiratory distress syndrome
  • extracorporeal membrane oxygenation
  • clinical evaluation